Skip to main content
. 2023 Jul 7;15(13):3529. doi: 10.3390/cancers15133529

Table 2.

IFD in allogeneic HCT recipients.

IFD Possible Probable Proven
Patients (n) 31 11 10
Median post-transplantation day 112 154 226
Positive Galactomannan (n) 0 5 3
Positive cultures (n) 0 6 7
Histopathological evidence 0 0 3
Second IFD episode (n) 0 1 2

IFD, Invasive fungal disease; HCT, Hematopoietic cell transplantation.